Most Recent
Clive Palmer’s companies slammed for misleading court in $30B dispute with WA
Energy & Natural Resources 2020-11-25 5:27 pm By Miklos Bolza

Two companies owned by billionaire Clive Palmer have suffered a legal setback, with a judge setting aside prior orders enforcing two awards in a $30 billion mining dispute with the Western Australian government and criticising the companies for misleading the court.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Rio Tinto execs’ trial can wait until COVID-19 vaccine, court hears
COVID-19 2020-11-23 10:32 pm By Spencer Fowler Steen

A former Rio Tinto executive living in the US who wants to appear in person at an upcoming trial in a case brought by ASIC says the hearing should be moved to next year when a COVID-19 vaccine will likely become available and he could travel to Australia to “mount a vital defence”.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Class action against Bayer’s Essure contraceptive drops claims against two manufacturers
Product Liability 2020-11-20 5:40 pm By Miklos Bolza

The lead applicant in a class action against Bayer over allegedly defective Essure contraceptive devices will ask the court to discontinue its claims against two makers of the controversial medical implants.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Insurers lose COVID-19 business interruption test case
Insurance 2020-11-18 11:31 pm By Cat Fredenburgh

Insurers will face a flood of pandemic-related claims after an appeals court ruled in a test case brought by the Insurance Council that certain infectious disease exclusions in business interruption cover do not apply to coronavirus-related claims.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Pfizer loses discovery lawsuit against Sandoz over Enbrel biosimilar
Intellectual Property 2020-11-13 4:58 pm By Cat Fredenburgh

A judge has dismissed Pfizer’s bid for preliminary discovery to pursue a possible patent infringement case against drug maker Sandoz over a generic version of its blockbuster rheumatoid arthritis biologic Enbrel.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Fuji Xerox can’t strike out EY, ex-director’s defences in case over $450M accounting scandal
Accounting 2020-11-09 2:49 pm By Cat Fredenburgh

A judge has denied Fuji Xerox’s attempt to strike out parts of the defences of Ernst & Young and a former Fuji director in a lawsuit over alleged massive accounting irregularities.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Rio Tinto execs want ASIC trial vacated due to COVID-19
Energy & Natural Resources 2020-11-04 2:21 pm By Cat Fredenburgh

Two former executives of mining giant Rio Tinto accused by ASIC of breaching their directors duties have asked the court to vacate an upcoming trial, after raising concerns that COVID-19 could affect their ability to appear.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Ripple Labs denies PayID is deceptively similar to trade mark of Aussie mobile banking system
Intellectual Property 2020-10-26 12:15 pm By Christine Caulfield

US cryptocurrency maker Ripple Labs has hit back at an intellectual property lawsuit brought by the Australian company behind the ubiquitous PayID mobile banking system, saying its PayID trade mark is neither substantially identical nor deceptively similar to the Aussie mark.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

CBA fined $150,000 for increasing problem gambler’s credit card limit
Financial Services 2020-10-23 5:30 pm By Christine Caulfield

The Commonwealth Bank of Australia has been fined $150,000 after a Federal Court judge found the bank had breached the law by increasing a problem gambler’s credit card limit but that the conduct was “not systematic, deliberate or covert”.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Judges unclear about Johnson & Johnson unit’s arguments in pelvic mesh appeal
Appeals 2020-10-23 2:57 pm By Miklos Bolza

A judge due to hear a high profile appeal by Johnson & Johnson unit Ethicon has expressed confusion about the grounds on which the medical device maker is challenging a landmark judgment putting it on the hook for potentially hundreds of million of dollars in damages over faulty pelvic mesh implants.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?